Announcements Trials
Browse Landscape

Phase

Phase 2 55Phase 3 44Phase 1/2 6Phase 1 5Phase 2/3 4Phase NA 3Phase 4 3Phase EARLY_PHASE1 1

Status

Completed 4Unknown 2

Sponsor Class

OTHER 6

Study Type

Interventional 6

Sponsor

Cancer Type

Plasma cell 6

Conditions

Multiple Myeloma 6Carcinoma, Hepatocellular 2Uveal Melanoma 1Prostatic Neoplasms 1Plasmacytoma 1Neoplasms, Plasma Cell 1Neoplasms 1Melanoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Immunoglobulin Light-chain Amyloidosis 1Carcinoma, Renal Cell 1Amyloidosis 1

Interventions

Dexamethasone 133Lenalidomide 58Bortezomib 56Calcium Dobesilate 43Melphalan 41carfilzomib 38pomalidomide 36Cyclophosphamide 35daratumumab 23belantamab mafodotin 21Peripheral Blood Stem Cell Transplantation 17ixazomib 16dexamethasone acetate 13Filgrastim 13Bendamustine Hydrochloride 13fludarabine phosphate 12fludarabine 12dexamethasone 21-phosphate 12Tacrolimus 12auricularum 11Whole-Body Irradiation 11liposomal doxorubicin 10iberdomide 10Prednisone 10venetoclax 9selinexor 9Mycophenolic Acid 9pembrolizumab 8isatuximab 8Cyclosporine 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 1/2 × Multiple Myeloma × Thalidomide × Clear all
NCT04891744 2021-05-18

Selinexor in Combination With Thalidomide and Dexamethasone in RRMM

Sichuan University

Phase 1/2 Unknown
48 enrolled
Plasma cell

Multiple Myeloma

NCT00966693 2020-11-04

Lenalidomide, Thalidomide and Dexamethasone in Treating Participants With Relapsed or Refractory Multiple Myeloma

M.D. Anderson Cancer Center

Phase 1/2 Completed
77 enrolled 19 charts
Plasma cell

Multiple Myeloma

NCT01057225 2017-12-12

Cyclophosphamide, Carfilzomib, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Active Multiple Myeloma

Mayo Clinic

Phase 1/2 Completed
64 enrolled 13 charts
Plasma cell

Multiple Myeloma

NCT00406978 2016-05-10

MPTD

University of Turin, Italy

Phase 1/2 Completed
24 enrolled
Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

NCT02145715 2015-06-26

MUKsix

University of Leeds

Phase 1/2 Unknown
54 enrolled
Plasma cell

Multiple Myeloma

NCT00081757 2010-07-02

An Open Protocol for the Compassionate Use of Thalidomide

University of Arkansas

Phase 1/2 Completed
250 enrolled
Plasma cell

Multiple Myeloma, Plasmacytoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡